Psychiatry & Neurology Doctors in Plainview, TX Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Dr. Bhupala Raju Kallepalli, MD Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 715 Houston St, Plainview, TX 79072 Phone: 806-291-4470    Fax: 806-293-7170

Mr. Victor Asaldo Gutierrez, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 715 Houston St, Plainview, TX 79072 Phone: 806-296-5327    Fax: 806-296-5133

John Simonds, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2700 Yonkers St, Plainview, TX 79072 Phone: 806-293-2636    Fax: 806-296-5804

News Archive

Disclosure of PEPFAR data would improve program's efficiency, quality, accountability

The U.S. government, and in particular U.S. Global AIDS Coordinator Ambassador Eric Goosby, the head of PEPFAR, "have a unique opportunity to make [the program's] money stretch farther and do more good, at very little cost to U.S. taxpayers: release the reams of data that PEPFAR and its contractors have already collected, at substantial cost - perhaps as much as $500 million each year," Mead Over, a senior fellow at the Center for Global Development (CGD), writes in the Center's "Global Health Policy" blog.

How SARS-CoV-2's spike protein highjacks the host cell trafficking machinery

Researchers at The Medical Research Council Laboratory of Molecular Biology have conducted a study showing how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein interacts with host cell factors in ways that promote the formation of syncytia.

Survey: Majority of U.S. pharmaceutical companies develop drugs for mental illness

Pharmaceutical research and biotechnology companies in New Jersey, California, New York and North Carolina are responsible for 192 of the 313 medicines in development today to treat mental illnesses, a new survey shows.

U.S. Navy and Solazyme to develop algae-derived advanced biofuel

Solazyme, Inc., the renewable oil production company and leader in algal synthetic biology, has been selected by the U.S. Department of Defense (DoD) to research, develop, and demonstrate commercial scale production of algae-derived advanced biofuel that meets the United States Navy's rigorous specifications for military tactical platforms.

Inhibiting MET signaling in glioblastoma has major therapeutic value

A recent discovery by Van Andel Research Institute (VARI) scientists enables the prediction of patient sensitivity to proposed drug therapies for glioblastoma - the most common and most aggressive malignant brain tumor in humans.

Read more Medical News

› Verified 3 days ago